CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹34 Cr | ₹28 Cr | ₹23 Cr | ₹21 Cr | ₹17 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CONCORD BIOTECH ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹28 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹21 Cr |
| Mar2021 | ₹17 Cr |
How is Deferred Tax Assets / Liabilities of CONCORD BIOTECH Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 21.23 | |
| Mar2024 | ₹28 Cr | 19.74 | |
| Mar2023 | ₹23 Cr | 11.77 | |
| Mar2022 | ₹21 Cr | 20.16 | |
| Mar2021 | ₹17 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹10,675.5 Cr | -1.7% | -16.7% | -38.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,713.0 Cr | 0.1% | -0.4% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,811.0 Cr | -1.1% | -7.1% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,052.0 Cr | 0.2% | -4.5% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,927.0 Cr | 0.2% | -4% | 6% | Stock Analytics | |
| CIPLA | ₹96,602.7 Cr | 0% | -9.1% | -18.5% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -1.7% |
-16.7% |
-38.9% |
| SENSEX | 0.6% |
-11.1% |
-6.2% |
You may also like the below Video Courses